VIA
MGNX icon

Vident Investment Advisory’s MacroGenics MGNX Stock Holding History

Vident Investment Advisory’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-69,303
Closed -$611K – 1337
2022
Q1 		$611K Buy
69,303
+11,550
+20% +$128K 0.02% 869
2021
Q4 		$927K Sell
57,753
-8,800
-13% -$166K 0.02% 736
2021
Q3 		$1.39M Sell
66,553
-4,754
-7% -$115K 0.04% 573
2021
Q2 		$1.92M Sell
71,307
-680
-0.9% -$19.9K 0.06% 422
2021
Q1 		$2.29M Hold
71,987
– – 0.08% 313
2020
Q4 		$1.65M Buy
71,987
+9,229
+15% +$212K 0.07% 363
2020
Q3 		$1.58M Sell
62,758
-4,342
-6% -$119K 0.08% 332
2020
Q2 		$1.87M Buy
+67,100
New +$1.17M 0.1% 214
2019
Q4 		– Sell
-92,279
Closed -$1.18M – 683
2019
Q3 		$1.18M Sell
92,279
-2,636
-3% -$38K 0.1% 151
2019
Q2 		$1.61M Sell
94,915
-9,856
-9% -$169K 0.13% 108
2019
Q1 		$1.88M Sell
104,771
-3,768
-3% -$65.1K 0.1% 297
2018
Q4 		$1.38M Buy
108,539
+4,053
+4% +$68K 0.08% 345
2018
Q3 		$2.24M Sell
104,486
-6,963
-6% -$148K 0.09% 302
2018
Q2 		$2.3M Buy
111,449
+21,716
+24% +$489K 0.09% 299
2018
Q1 		$2.18M Buy
89,733
+24,090
+37% +$585K 0.09% 299
2017
Q4 		$1.25M Buy
65,643
+374
+0.6% +$6.98K 0.06% 342
2017
Q3 		$1.21M Buy
65,269
+1,977
+3% +$34.2K 0.07% 344
2017
Q2 		$1.11M Buy
63,292
+18,309
+41% +$349K 0.09% 312
2017
Q1 		$837K Buy
44,983
+7,496
+20% +$145K 0.08% 322
2016
Q4 		$766K Buy
37,487
+10,904
+41% +$274K 0.09% 299
2016
Q3 		$795K Sell
26,583
-900
-3% -$26.8K 0.11% 309
2016
Q2 		$742K Sell
27,483
-18,259
-40% -$412K 0.1% 301
2016
Q1 		$858 Buy
45,742
+21,890
+92% +$417K 0.05% 357
2015
Q4 		$739K Buy
+23,852
New +$725K 0.09% 344

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vident Investment Advisory's MGNX Position: Q2 2022 in Review

Vident Investment Advisory sold out of MacroGenics (MGNX) in Q2 2022, closing a stake of 69,303 shares — an estimated $611K sold.

Vident Investment Advisory first reported a position in MGNX in Q4 2015 and held it in 24 quarters. The position peaked at $2.3M in Q2 2018. 133 funds tracked by Wall St. Rank hold MGNX as of Q2 2022.

  • Vident Investment Advisory reported no remaining MacroGenics position as of Q2 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 69,303 MacroGenics shares in Q2 2022, an estimated $611K.
  • Vident Investment Advisory first reported a position in MacroGenics in Q4 2015 and held it in 24 quarters.
  • Vident Investment Advisory's MacroGenics position peaked at $2.3M in Q2 2018.
  • 133 funds tracked by Wall St. Rank held MacroGenics as of Q2 2022.

Based on Vident Investment Advisory's 13F filing for Q2 2022, filed 15 Aug 2022.